SCHEMBL10282081

SCHEMBL10282081

Cc1cncc(C(=O)N(C)Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 2/20 0.58
▸ ATM Q13315 1/20 0.53
▸ SMYD3 Q9H7B4 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HTT P42858 2/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ GPBAR1 Q8TDU6 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TPMT P51580 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ ACKR3 P25106 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ CDK7 P50613 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12048998 0.85 HCAR2 (0.62) HCAR2ATMSMYD3KDM4EALDH1A1
SCHEMBL24576770 0.83 HCAR2 (0.60) HCAR2ATMSMYD3KDM4EALDH1A1
SCHEMBL4056048 0.79 ATM (0.59) HCAR2ATMSMYD3KDM4EALDH1A1
SCHEMBL12678010 0.79 HCAR2 (0.55) HCAR2ATMSMYD3KDM4EALDH1A1
SCHEMBL12677900 0.76 HPGD (0.57) HCAR2ATMSMYD3ALDH1A1MEN1
SCHEMBL4196322 0.76 HCAR2 (0.67) HCAR2ATMSMYD3KDM4EALDH1A1
SCHEMBL31134038 0.76 HCAR2 (0.67) HCAR2ATMSMYD3KDM4EALDH1A1
SCHEMBL17297343 0.76 HCAR2 (0.51) HCAR2ATMSMYD3KDM4EALDH1A1
SCHEMBL17297327 0.75 HCAR2 (0.50) HCAR2ATMSMYD3KDM4EALDH1A1
SCHEMBL12677914 0.75 HCAR2 (0.50) HCAR2ATMSMYD3ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2287161-B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2012-05-09 — — EP disclosed
Send feedback